← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2011Last known activity
Sep 4, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT03645109Lead sponsorPhase 3Sep 4, 2018
- NCT03645109Overall official - principal investigatorPhase 3Sep 4, 2018
- NCT01541891Overall official - principal investigatorPhase 2Sep 1, 2011
- NCT01541904Overall official - principal investigatorPhase 2Mar 1, 2011
Details
- Last known activity
- Sep 4, 2018